Prognostic Significance of Cystic Biliary Dilatation in Primary Sclerosing Cholangitis

Background/Aims: Primary sclerosing cholangitis (PSC) is a chronic, progressive disease characterized by inflammatory and fibrotic strictures in the intrahepatic and/or extrahepatic bile ducts. Typical cholangiographic findings include multifocal, annular, short bile duct strictures with minimal upstream dilatation. However, in some patients, this dilatation progresses to cystic dimensions. The current study aimed to investigate whether the clinical features and prognosis of patients with cystic dilatation (CD) of the bile ducts differ from those of patients with classic cholangiographic PSC. Materials and Methods: Demographic data, laboratory and clinical findings, and prognostic outcomes of patients with CD of the bile ducts who underwent endoscopic retrograde cholangiopancreatography (ERCP) and/or percutaneous transhepatic biliary drainage at the hospital between 2017 and 2023 were compared with those of patients without CD. Results: Of the 37 patients, 5 (13.5%) had cystic biliary dilatation. Median follow-up was 24 months (range, 12-62) in the CD group and 20 months (range, 8-52) in the non-cystic group. Patients with CD had a higher frequency of cholangitis (median attacks per patient, 1.6 vs. 0.3; P < .001), a greater proportion of recurrent cholangitis (4/5 [80%] vs. 7/32 [21.8%]; P = .038), an increased risk of end-stage liver disease (3/5 [60%] vs. 5/32 [15.6%]; P = .025), and higher mortality (1/5 [20%] vs. 2/32 [6.25%]; P = .045). Median transplant-free survival was significantly shorter in the cystic group (7.1 years [95% CI, 1-9] vs. 19.5 years; P = .017). Conclusion: Cystic dilatation appears to be a clinically relevant prognostic feature in patients with primary sclerosing cholangitis, however, confirmation in larger studies is warranted. Cite this article as: Parlar YE, Öztürk B, Keskin O, et al. Prognostic significance of cystic biliary dilatation in primary sclerosing cholangitis. Turk J Gastroenterol. Published online March 25, 2026. doi:10.5152/tjg.2026.26055.

Authors

Institutions

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2026-03-01
DOI
https://doi.org/10.5152/tjg.2026.25055
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic Significance of Cystic Biliary Dilatation in Primary Sclerosing Cholangitis

Erkan Parlak, Cenk Sökmensüer, Taylan Kav, Bengi Özgün Öztürk et al.
SHILAP Revista de lepidopterología
Liver Diseases and Immunity
article

Prognostic Significance of Cystic Biliary Dilatation in Primary Sclerosing Cholangitis

Erkan Parlak, Cenk Sökmensüer, Taylan Kav, Bengi Özgün Öztürk, Yavuz Emre Parlar, Ahmet Doğrul, Onur Keskin, Sabir İsrafilov
article en

Abstract

Background/Aims: Primary sclerosing cholangitis (PSC) is a chronic, progressive disease characterized by inflammatory and fibrotic strictures in the intrahepatic and/or extrahepatic bile ducts. Typical cholangiographic findings include multifocal, annular, short bile duct strictures with minimal upstream dilatation. However, in some patients, this dilatation progresses to cystic dimensions. The current study aimed to investigate whether the clinical features and prognosis of patients with cystic dilatation (CD) of the bile ducts differ from those of patients with classic cholangiographic PSC. Materials and Methods: Demographic data, laboratory and clinical findings, and prognostic outcomes of patients with CD of the bile ducts who underwent endoscopic retrograde cholangiopancreatography (ERCP) and/or percutaneous transhepatic biliary drainage at the hospital between 2017 and 2023 were compared with those of patients without CD. Results: Of the 37 patients, 5 (13.5%) had cystic biliary dilatation. Median follow-up was 24 months (range, 12-62) in the CD group and 20 months (range, 8-52) in the non-cystic group. Patients with CD had a higher frequency of cholangitis (median attacks per patient, 1.6 vs. 0.3; P < .001), a greater proportion of recurrent cholangitis (4/5 [80%] vs. 7/32 [21.8%]; P = .038), an increased risk of end-stage liver disease (3/5 [60%] vs. 5/32 [15.6%]; P = .025), and higher mortality (1/5 [20%] vs. 2/32 [6.25%]; P = .045). Median transplant-free survival was significantly shorter in the cystic group (7.1 years [95% CI, 1-9] vs. 19.5 years; P = .017). Conclusion: Cystic dilatation appears to be a clinically relevant prognostic feature in patients with primary sclerosing cholangitis, however, confirmation in larger studies is warranted. Cite this article as: Parlar YE, Öztürk B, Keskin O, et al. Prognostic significance of cystic biliary dilatation in primary sclerosing cholangitis. Turk J Gastroenterol. Published online March 25, 2026. doi:10.5152/tjg.2026.26055.

SHILAP Revista de lepidopterología
Ministry of Health (TR), TOBB University of Economics and Technology (TR), Education Training And Research (US), Hacettepe University (TR)
Good health and well-being
Openalex Percentile: Top 3%
Liver Diseases and Immunity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.